Journal of Geriatric Cardiology2016，Vol.13Issue(8)：P.712-717,6.
Pentraxin 3 （PTX3） promoter methylation associated with PTX3 plasma levels and neutrophil to lymphocyte ratio in coronary artery disease
Tang-Meng GUO 1Li-Li HUANG 2Kai LIU 3Li KE 1Zhi-Jian LUO 4Yun-Qiao LI 1Xing-Lin CHEN 1Bei CHENG1
作者信息
- 1. Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei China Institute of Geriatrics, Union Hospital, Tongii Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
- 2. Department of Clinical Laboratory Medicine, People''s Hospital of Dongxihu District, Wuhan, Hubei, China
- 3. Department of Cardiology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, China
- 4. Department of Neurology, the First Hospital of Jingzhou, Clinical Medical College, Yangtze University, Jingzhou, Hubei, China
- 折叠
摘要
关键词
Coronary artery disease/ Lymphocyte/ Methylation/ Neutrophil/ Pentraxin 3分类
医药卫生引用本文复制引用
Tang-Meng GUO,Li-Li HUANG,Kai LIU,Li KE,Zhi-Jian LUO,Yun-Qiao LI,Xing-Lin CHEN,Bei CHENG..Pentraxin 3 （PTX3） promoter methylation associated with PTX3 plasma levels and neutrophil to lymphocyte ratio in coronary artery disease[J].Journal of Geriatric Cardiology,2016,13(8):P.712-717,6.
